ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 109 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,481 | -35.4% | 4,012 | -9.1% | 0.05% | -33.8% |
| Q2 2023 | $124,547 | +43.0% | 4,415 | -12.8% | 0.07% | +54.2% |
| Q1 2023 | $87,118 | -38.3% | 5,065 | -27.7% | 0.05% | -35.1% |
| Q4 2022 | $141,181 | +35.8% | 7,010 | +45.5% | 0.07% | +80.5% |
| Q3 2022 | $104,000 | -22.4% | 4,819 | +0.7% | 0.04% | -18.0% |
| Q2 2022 | $134,000 | +34.0% | 4,786 | +120.7% | 0.05% | +11.1% |
| Q1 2022 | $100,000 | -48.5% | 2,169 | -5.9% | 0.04% | -38.4% |
| Q4 2021 | $194,000 | -23.3% | 2,305 | -39.2% | 0.07% | -34.2% |
| Q3 2021 | $253,000 | +19.3% | 3,794 | -5.0% | 0.11% | +27.6% |
| Q2 2021 | $212,000 | -15.9% | 3,992 | -31.4% | 0.09% | -17.9% |
| Q1 2021 | $252,000 | -15.2% | 5,819 | +1.9% | 0.11% | -13.8% |
| Q4 2020 | $297,000 | – | 5,711 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |